Analgesics: Page 26

Septodont acquires OraVerse from Novalar
By Kathy Kincade
Septodont has acquired the OraVerse product line from Novalar Pharmaceuticals, the companies announced today. OraVerse is the first local anesthesia reversal agent to gain U.S. Food and Drug Administration approval.
March 17, 2011
2009 03 06 12 05 35 84 Fear Needle
Needle-free anesthesia in phase III clinical studies
By DrBicuspid.com staff writers
A nasal mist local anesthetic aimed at achieving anesthesia in the maxillary arch is moving forward with its efforts to gain U.S. Food and Drug Administration approval.
March 14, 2011
Perio drug reduces risk of osteoporosis, heart disease
By DrBicuspid.com staff writers
A drug approved by the U.S. Food and Drug Administration (FDA) for treating periodontal disease could also significantly reduce the risk of osteoporosis and cardiovascular disease in postmenopausal women, according to a study in the Journal of the American Dental Association.
March 10, 2011
Haptics make injection simulator more user-friendly
By DrBicuspid.com staff writers
Sensable Technologies will showcase several touch-enabled medical simulation applications for surgical training at the South by Southwest conference in Austin, TX this week, the company announced.
March 9, 2011
Many U.S. states revising dental sedation guidelines
By DrBicuspid.com staff writers
As part of Sedation Safety Week, DOCS Education has released a comprehensive list of all the U.S. states and Canadian provinces that changed or updated dental sedation regulations since January 2010.
March 9, 2011
Epileptic drug can cause oral birth defects
By DrBicuspid.com staff writers
New data suggest that the drug Topamax (topiramate) and its generic versions increase the risk for cleft lip and cleft palate in babies born to women who use the medication during pregnancy, the U.S. Food and Drug Administration is warning.
March 3, 2011
Buyer's Guide Update: Anesthetic products and delivery systems
By Kathy Kincade
February 17, 2011
Heraeus updates Gluma desensitizing product
By DrBicuspid.com staff writers
Heraeus has launched Gluma Desensitizer PowerGel, a new one-step gel formula desensitizer that allows for accurate control and placement to reduce or eliminate dentinal hypersensitivity.
February 15, 2011
Merck wins latest Fosamax/ONJ lawsuit
By DrBicuspid.com staff writers
A state court in New Jersey has found in favor of Merck in the Rosenberg v. Merck case, rejecting the claims of a woman who blamed her dental and jaw-related problems on her Fosamax use.
February 13, 2011
Tenn. legalizes Botox use for oral surgeons
By Rabia Mughal
The Tennessee dental board has approved the use of Botox injections by oral and maxillofacial surgeons and considerations are under way that might allow general dentists to use the drug in the future.
February 3, 2011
2010 05 06 09 46 14 716 Botox 70
Nitrous oxide may increase heart attack risk
By DrBicuspid.com staff writers
Patients receiving nitrous oxide as part of general anesthesia for surgery may be at increased long-term risk of myocardial infarction, according to a new study in Anesthesia & Analgesia.
January 30, 2011
Milestone to provide STA system to Fla. dental clinics
By DrBicuspid.com staff writers
Milestone Scientific will provide Towncare Dental Partnership with its Single Tooth Anesthesia (STA) system through a new distributor agreement that covers all of Towncare's dental offices in Florida.
January 24, 2011
Previous Page
Page 26 of 43
Next Page